Remus Pharmaceuticals Approves Main Board Migration And Dominican Republic Subsidiary

Board approved migration from NSE Emerge to the NSE and BSE Main Boards, subject to shareholder, exchange and regulatory approvals. It also approved a 51%+ owned Dominican Republic pharmaceutical distribution subsidiary and appointed Ashutosh Valani as an independent director for a five-year term.